Should leftover rectal lesions be removed or watched? small trial aims to find out.

NCT ID NCT07192627

Not yet recruiting Knowledge-focused Sponsor: Assiut University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at people with rectal cancer who have small leftover spots after chemoradiotherapy. One group will have these spots removed with a scope, while the other group will just be watched closely. The goal is to see which approach leads to better cancer control after one year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: endoscopic mucosal dissection (procedure)
What this could lead to: If successful, this could clarify whether removing small leftover lesions after chemoradiotherapy improves cancer control compared to simply watching them.
What could go wrong: This is a very small, early-phase study with only 20 participants, so results may not apply broadly. The best approach for these lesions remains uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECTAL ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

rectal cancer rectal neoplasm rectum adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RECTAL CANCER

Contacts and locations

Locations

Assiut University

Asyut, 71515, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.